Sanjiv Navangul, managing director and CEO, Bharat Serums and Vaccines, outlines, in a wide ranging interview, the firm’s gameplan to establish itself as a “force to reckon with” in women’s health - it goes beyond drugs and encompasses devices and potentially digital therapeutics as well. The former Janssen India chief also weighs in on the worrying industry-wide input cost escalation scenario and supply chain turbulence.